Virtual screening, identification and experimental testing of novel inhibitors of PBEF1/Visfatin/NMPRTase for glioma therapy
2011

New Inhibitors for Glioma Therapy

Sample size: 6 publication 10 minutes Evidence: moderate

Author Information

Author(s): Chandra Nagasuma, Bhagavat Raghu, Sharma Eshita, Sreekanthreddy P, Somasundaram Kumaravel

Primary Institution: Indian Institute of Science, Bangalore, India

Hypothesis

Can novel inhibitors of PBEF1/Visfatin/NMPRTase effectively inhibit glioma cell growth?

Conclusion

A novel inhibitor has been identified that effectively inhibits glioma cell growth.

Supporting Evidence

  • Two compounds were found to significantly inhibit NMPRTase activity.
  • Compound 5 showed the highest efficacy in inhibiting glioma cell growth.
  • The study utilized a virtual screening approach to identify potential inhibitors.

Takeaway

Researchers found new compounds that can stop brain cancer cells from growing by blocking a specific enzyme.

Methodology

Virtual screening of over 13,000 compounds followed by in vitro testing of selected candidates.

Potential Biases

Potential bias in selecting compounds based on docking results.

Limitations

The study primarily focused on a limited number of compounds and cell lines.

Participant Demographics

Not applicable.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/2043-9113-1-5

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication